Published on 26 Mar 2024 on Benzinga
Why Stoke Therapeutics Shares Are Trading Higher By Around 70%; Here Are 20 Stocks Moving Premarket...
Shares of Stoke Therapeutics, Inc. STOK rose sharply in today’s pre-market trading after the company announced Phase 1/2a data supporting the potential for STK-001 in Dravet syndrome.
Stoke Therapeutics shares jumped 69.7% to $11.03 in pre-market trading
NASDAQ.BZFD price evolution
NASDAQ.STOK price evolution
NASDAQ.MESO price evolution
NASDAQ.OPGN price evolution
NASDAQ.GDS price evolution
Want to become a better investor?
Start tracking your investments with Statfolio
Sign up for free